TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07560085: Efficacy and Safety of SynFlow Duro System in the Treatment of Post Cardiotomy Cardiogenic Shock: a Prospective, Multicenter, Single-arm Clinical Trial

Sponsor: ForQaly Medical (Shanghai) Co., Ltd · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 60 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$7,038,400

Rescue Site Savings

+$4,648,000

Unlock Full NCT07560085 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07560085 Rescue Dossier →